Dermapharm Holding SE

Equities

DMP

DE000A2GS5D8

Pharmaceuticals

Market Closed - Xetra 09:07:38 29/04/2024 pm IST 5-day change 1st Jan Change
31.5 EUR +0.64% Intraday chart for Dermapharm Holding SE -3.67% -25.60%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
DERMAPHARM : Berenberg keeps its Buy rating ZD
Dermapharm Holding SE Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Dpa-AFX Overview: COMPANIES from 14.03.2024 - 15:15 DP
Dermapharm looks cautiously into the future - missing Covid business DP
DERMAPHARM : Berenberg reaffirms its Buy rating ZD
DERMAPHARM : Berenberg reiterates its Buy rating ZD
Dpa-AFX Overview: COMPANIES from 15.11.2023 - 15:15 DP
Dermapharm grows thanks to new subsidiary - nutritional supplements in demand DP
DERMAPHARM : Jefferies reiterates its Buy rating ZD
Dermapharm Holding SE Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Dermapharm grows thanks to subsidiary Arkopharma and dietary supplements DP
DERMAPHARM : Buy rating from Berenberg ZD
DERMAPHARM : Berenberg maintains a Buy rating ZD
Dermapharm Holding SE Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
DERMAPHARM : Jefferies keeps its Buy rating ZD
Dermapharm move to SDax top - Jefferies praises profitability DP
Dermapharm becomes more optimistic after first half-year - share price jumps DP
Jefferies leaves Dermapharm at 'Buy' - Target 65 euros DP
DERMAPHARM : Jefferies reiterates its Buy rating ZD
Dermapharm becomes more optimistic after first half year DP
Dermapharm Holding SE Provides Earnings Guidance for the Year 2023 CI
DERMAPHARM : Jefferies gives a Buy rating ZD
DERMAPHARM : Berenberg keeps its Buy rating ZD
WEEKLY PREVIEW: Dates until June 20, 2023 DP
WEEKLY PREVIEW: Dates until June 16, 2023 DP
Chart Dermapharm Holding SE
More charts
Dermapharm Holding SE is a Germany-based company engaged in manufacturing of patent-free branded pharmaceuticals. The Company operates through two segments: Branded pharmaceuticals and other healthcare products, which includes in-house development, in-house production, and distribution of branded pharmaceuticals and other healthcare products, and Parallel import business, which operates under the axicorp brand. It holds around 950 marketing authorizations for more than 250 active pharmaceutical ingredients, which are marketed as pharmaceuticals, dietary supplements or supplemental balanced diets. The Company offers its products through a number of brands, including Dekristol, Ampho Moronal, Keltican, Tromcardin, among others. It is active primarily in Germany, Switzerland and Austria. Additionally, it operates production facility in Germany. Trommsdorff & GmbH Co KG is a subsidiary of the Company.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
31.5 EUR
Average target price
56.9 EUR
Spread / Average Target
+80.63%
Consensus
  1. Stock Market
  2. Equities
  3. DMP Stock
  4. News Dermapharm Holding SE
  5. Dermapharm To Buy Herbal Medicines Group Apharma TopCo For $460 Million